Fennec Pharmaceuticals, Inc. (FENC)
10.71
+0.08
(+0.75%)
USD |
NASDAQ |
Oct 09, 16:00
10.68
-0.02
(-0.23%)
After-Hours: 20:00
Fennec Pharmaceuticals Market Cap : 375.21M for Oct. 9, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 09, 2026 | 375.21M |
| October 08, 2026 | 372.41M |
| October 07, 2026 | 362.95M |
| October 06, 2026 | 362.60M |
| October 05, 2026 | 372.06M |
| October 02, 2026 | 357.35M |
| October 01, 2026 | 361.90M |
| September 30, 2026 | 373.11M |
| September 29, 2026 | 378.37M |
| September 28, 2026 | 383.62M |
| September 25, 2026 | 371.54M |
| September 24, 2026 | 372.06M |
| September 23, 2026 | 368.21M |
| September 22, 2026 | 385.72M |
| September 21, 2026 | 382.22M |
| September 18, 2026 | 372.06M |
| September 17, 2026 | 377.67M |
| September 16, 2026 | 369.61M |
| September 15, 2026 | 372.76M |
| September 14, 2026 | 375.56M |
| September 11, 2026 | 383.97M |
| September 10, 2026 | 395.88M |
| September 09, 2026 | 408.15M |
| September 08, 2026 | 436.17M |
| September 04, 2026 | 434.07M |
| Date | Value |
|---|---|
| September 03, 2026 | 439.68M |
| September 02, 2026 | 431.27M |
| September 01, 2026 | 421.46M |
| August 31, 2026 | 432.67M |
| August 28, 2026 | 429.87M |
| August 27, 2026 | 412.35M |
| August 26, 2026 | 426.36M |
| August 25, 2026 | 410.25M |
| August 24, 2026 | 399.39M |
| August 21, 2026 | 395.53M |
| August 20, 2026 | 397.64M |
| August 19, 2026 | 415.85M |
| August 18, 2026 | 415.85M |
| August 17, 2026 | 414.45M |
| August 14, 2026 | 410.60M |
| August 13, 2026 | 422.51M |
| August 12, 2026 | 414.45M |
| August 11, 2026 | 447.73M |
| August 10, 2026 | 383.27M |
| August 07, 2026 | 405.52M |
| August 06, 2026 | 379.77M |
| August 05, 2026 | 363.37M |
| August 04, 2026 | 349.21M |
| August 03, 2026 | 331.25M |
| July 31, 2026 | 330.56M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.405B |
| Alnylam Pharmaceuticals, Inc. | 31.12B |
| Anika Therapeutics, Inc. | 262.04M |
| Savara, Inc. | 1.011B |
| Vericel Corp. | 2.052B |
Market Cap Related Metrics
| PS Ratio | 5.925 |
| Price to Book Value | 8.841 |
| Price | 10.71 |
| Earnings Yield | -1.20% |